Sinovac Biotech Ltd (SVA) — Net Asset Momentum
Sinovac Biotech Ltd (SVA) recorded a net asset momentum of -5.4% as of December 2023, with net assets of $12.02 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Sinovac Biotech Ltd (SVA) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Sinovac Biotech Ltd Net Asset Momentum (1998–2023)
This chart tracks Sinovac Biotech Ltd's year-over-year net asset growth across 25 annual reporting periods from 1998 to 2023. The most recent momentum reading is -5.4%, with net assets of $12.02 Billion USD as of December 2023. Read Sinovac Biotech Ltd (SVA) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Sinovac Biotech Ltd (1998–2023)
The table below shows the complete annual net asset history for Sinovac Biotech Ltd from 1998 to 2023, covering 25 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Sinovac Biotech Ltd market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | $12.02 Billion | $13.66 Billion | $1.64 Billion | ▼ -5.4% |
| 2022 | $12.71 Billion | $14.11 Billion | $1.40 Billion | ▼ -8.4% |
| 2021 | $13.88 Billion | $16.75 Billion | $2.87 Billion | ▲ +1138.8% |
| 2020 | $1.12 Billion | $1.90 Billion | $781.20 Million | ▲ +218.0% |
| 2019 | $352.19 Million | $452.30 Million | $100.10 Million | ▲ +20.6% |
| 2018 | $291.93 Million | $369.78 Million | $77.85 Million | ▲ +125.1% |
| 2017 | $129.67 Million | $211.35 Million | $81.69 Million | ▲ +0.0% |
| 2016 | $129.67 Million | $211.35 Million | $81.69 Million | ▼ -5.0% |
| 2015 | $136.50 Million | $202.93 Million | $66.42 Million | ▼ -3.7% |
| 2014 | $141.73 Million | $238.53 Million | $96.80 Million | ▼ -1.3% |
| 2013 | $143.64 Million | $240.69 Million | $97.05 Million | ▲ +11.0% |
| 2012 | $129.44 Million | $208.76 Million | $79.33 Million | ▼ -10.9% |
| 2011 | $145.30 Million | $215.91 Million | $70.61 Million | ▼ -1.7% |
| 2010 | $147.76 Million | $214.36 Million | $66.60 Million | ▲ +74.9% |
| 2009 | $84.47 Million | $145.48 Million | $61.01 Million | ▲ +57.5% |
| 2008 | $53.64 Million | $77.44 Million | $23.80 Million | ▲ +63.0% |
| 2007 | $32.90 Million | $57.45 Million | $24.55 Million | ▲ +54.4% |
| 2006 | $21.31 Million | $37.01 Million | $15.70 Million | ▲ +29.1% |
| 2005 | $16.51 Million | $23.37 Million | $6.86 Million | ▲ +6.1% |
| 2004 | $15.56 Million | $22.42 Million | $6.86 Million | ▲ +42.9% |
| 2003 | $10.89 Million | $14.90 Million | $4.01 Million | ▲ +10848.5% |
| 2002 | $99.44K | $236.25K | $136.81K | ▲ +114.6% |
| 2001 | $-682.96K | $269.19K | $952.15K | ▲ +0.0% |
| 2000 | $-682.96K | $269.19K | $952.15K | ▼ -2454.5% |
| 1998 | $29.01K | $33.51K | $4.50K | — |